CAPTRUST Financial Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,596
Closed -$92.2K 2586
2025
Q1
$92.2K Buy
+11,596
New +$92.2K ﹤0.01% 2239
2023
Q3
Sell
-6,091
Closed -$286K 2641
2023
Q2
$286K Buy
6,091
+502
+9% +$23.6K ﹤0.01% 2013
2023
Q1
$235K Buy
+5,589
New +$235K ﹤0.01% 1941
2022
Q3
Sell
-402
Closed -$13K 3674
2022
Q2
$13K Sell
402
-196
-33% -$6.34K ﹤0.01% 3617
2022
Q1
$20K Buy
598
+368
+160% +$12.3K ﹤0.01% 3393
2021
Q4
$10K Sell
230
-209
-48% -$9.09K ﹤0.01% 3722
2021
Q3
$19K Sell
439
-89
-17% -$3.85K ﹤0.01% 3205
2021
Q2
$30K Buy
528
+12
+2% +$682 ﹤0.01% 2842
2021
Q1
$39K Sell
516
-387
-43% -$29.3K ﹤0.01% 2595
2020
Q4
$78K Buy
903
+789
+692% +$68.2K ﹤0.01% 1628
2020
Q3
$7K Hold
114
﹤0.01% 2433
2020
Q2
$5K Buy
+114
New +$5K ﹤0.01% 2399
2018
Q3
Sell
-4
Closed -$1K 1685
2018
Q2
$1K Sell
4
-9
-69% -$2.25K ﹤0.01% 1467
2018
Q1
$2K Buy
+13
New +$2K ﹤0.01% 1253